These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

390 related items for PubMed ID: 16791802

  • 1. Diagnostic role of 18F-FDG PET in gastric MALT lymphoma.
    Ambrosini V, Rubello D, Castellucci P, Nanni C, Farsad M, Zinzani P, Alavi A, Tehranipour N, Al-Nahhas A, Fanti S.
    Nucl Med Rev Cent East Eur; 2006; 9(1):37-40. PubMed ID: 16791802
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Computed tomography, magnetic resonance imaging and positron emission tomography in non-Hodgkin's lymphoma.
    Rodriguez M.
    Acta Radiol Suppl; 1998; 417():1-36. PubMed ID: 9645167
    [Abstract] [Full Text] [Related]

  • 4. 18F-FDG PET/CT in gastric MALT lymphoma: a bicentric experience.
    Albano D, Bertoli M, Ferro P, Fallanca F, Gianolli L, Picchio M, Giubbini R, Bertagna F.
    Eur J Nucl Med Mol Imaging; 2017 Apr; 44(4):589-597. PubMed ID: 27619357
    [Abstract] [Full Text] [Related]

  • 5. 18F-FDG uptake and its clinical relevance in primary gastric lymphoma.
    Yi JH, Kim SJ, Choi JY, Ko YH, Kim BT, Kim WS.
    Hematol Oncol; 2010 Jun; 28(2):57-61. PubMed ID: 19593742
    [Abstract] [Full Text] [Related]

  • 6. 18F-FDG PET in malignant lymphoma: significance of positive findings.
    Castellucci P, Zinzani P, Pourdehnad M, Alinari L, Nanni C, Farsad M, Battista G, Tani M, Stefoni V, Canini R, Monetti N, Rubello D, Alavi A, Franchi R, Fanti S.
    Eur J Nucl Med Mol Imaging; 2005 Jul; 32(7):749-56. PubMed ID: 15785956
    [Abstract] [Full Text] [Related]

  • 7. Prognostic value of SUVmax measured by pretreatment 18F-FDG PET/CT in patients with primary gastric lymphoma.
    Hwang JP, Lim I, Byun BH, Kim BI, Choi CW, Lim SM.
    Nucl Med Commun; 2016 Dec; 37(12):1267-1272. PubMed ID: 27482643
    [Abstract] [Full Text] [Related]

  • 8. [18F] FDG PET in gastric non-Hodgkin's lymphoma.
    Rodriguez M, Ahlström H, Sundín A, Rehn S, Sundström C, Hagberg H, Glimelius B.
    Acta Oncol; 1997 Dec; 36(6):577-84. PubMed ID: 9408147
    [Abstract] [Full Text] [Related]

  • 9. Prognostic value of positron emission tomography (PET) with fluorine-18 fluorodeoxyglucose ([18F]FDG) after first-line chemotherapy in non-Hodgkin's lymphoma: is [18F]FDG-PET a valid alternative to conventional diagnostic methods?
    Spaepen K, Stroobants S, Dupont P, Van Steenweghen S, Thomas J, Vandenberghe P, Vanuytsel L, Bormans G, Balzarini J, De Wolf-Peeters C, Mortelmans L, Verhoef G.
    J Clin Oncol; 2001 Jan 15; 19(2):414-9. PubMed ID: 11208833
    [Abstract] [Full Text] [Related]

  • 10. 18F-Fluoro-deoxy-glucose positron emission tomography in lymphoma of mucosa-associated lymphoid tissue: histology makes the difference.
    Hoffmann M, Wöhrer S, Becherer A, Chott A, Streubel B, Kletter K, Raderer M.
    Ann Oncol; 2006 Dec 15; 17(12):1761-5. PubMed ID: 16980600
    [Abstract] [Full Text] [Related]

  • 11. The role of baseline 2-[18 F]-FDG-PET/CT metrics and radiomics features in predicting primary gastric lymphoma diagnosis.
    Albano D, Calabrò A, Dondi F, Bagnasco S, Tucci A, Bertagna F.
    Hematol Oncol; 2024 Mar 15; 42(2):e3266. PubMed ID: 38444261
    [Abstract] [Full Text] [Related]

  • 12. Comparison between endoscopic macroscopic classification and F-18 FDG PET findings in gastric mucosa-associated lymphoid tissue lymphoma patients.
    Hirose Y, Kaida H, Ishibashi M, Uozumi J, Arikawa S, Kurata S, Hayabuchi N, Nakahara K, Ohshima K.
    Clin Nucl Med; 2012 Feb 15; 37(2):152-7. PubMed ID: 22228338
    [Abstract] [Full Text] [Related]

  • 13. Mucosa-associated lymphoid tissue lymphoma studied with FDG-PET: a comparison with CT and endoscopic findings.
    Enomoto K, Hamada K, Inohara H, Higuchi I, Tomita Y, Kubo T, Hatazawa J.
    Ann Nucl Med; 2008 May 15; 22(4):261-7. PubMed ID: 18535876
    [Abstract] [Full Text] [Related]

  • 14. Diagnostic accuracy of PET/CT in patients with extranodal marginal zone MALT lymphoma.
    Perry C, Herishanu Y, Metzer U, Bairey O, Ruchlemer R, Trejo L, Naparstek E, Sapir EE, Polliack A.
    Eur J Haematol; 2007 Sep 15; 79(3):205-9. PubMed ID: 17662066
    [Abstract] [Full Text] [Related]

  • 15. 18F-Fluorodeoxyglucose (FDG)-positron emission tomography/computed tomography in mucosa-associated lymphoid tissue lymphoma: variation in 18F-FDG avidity according to site involvement.
    Park SH, Lee JJ, Kim HO, Lee DY, Suh C, Jung HY, Choi KD, Kim DH, Huh J, Ryu JS.
    Leuk Lymphoma; 2015 Sep 15; 56(12):3288-94. PubMed ID: 25804932
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of Positron Emission Tomography/Computed Tomography in Gastric Mucosa-associated Lymphoid Tissue Lymphoma.
    Hwang JW, Jee SR, Lee SH, Kim JH, Seol SY, Lee SM.
    Korean J Gastroenterol; 2016 Apr 25; 67(4):183-8. PubMed ID: 27112244
    [Abstract] [Full Text] [Related]

  • 17. Role in staging and prognostic value of pretherapeutic F-18 FDG PET/CT in patients with gastric MALT lymphoma without high-grade transformation.
    Park YJ, Hyun SH, Moon SH, Lee KH, Min BH, Lee JH, Kim WS, Kim SJ, Choi JY.
    Sci Rep; 2021 Apr 29; 11(1):9243. PubMed ID: 33927319
    [Abstract] [Full Text] [Related]

  • 18. Can Interim 18F-FDG PET or Diffusion-Weighted MRI Predict End-of-Treatment Outcome in FDG-Avid MALT Lymphoma After Rituximab-Based Therapy?: A Preliminary Study in 15 Patients.
    Mayerhoefer ME, Karanikas G, Kletter K, Kiesewetter B, Weber M, Rausch I, Pones M, Simonitsch-Klupp I, Müllauer L, Dolak W, Lukas J, Raderer M.
    Clin Nucl Med; 2016 Nov 29; 41(11):837-843. PubMed ID: 27648705
    [Abstract] [Full Text] [Related]

  • 19. Standardised uptake value of 18F-FDG on staging PET/CT in newly diagnosed patients with different subtypes of non-Hodgkin's lymphoma.
    Papajík T, Mysliveček M, Sedová Z, Buriánková E, Procházka V, Koranda P, Raida L, Kubová Z, Palová M, Kučerová L, Flodr P, Jarkovský J, Dušek L, Indrák K.
    Eur J Haematol; 2011 Jan 29; 86(1):32-7. PubMed ID: 20874822
    [Abstract] [Full Text] [Related]

  • 20. 18-FDG-PET as a prognostic indicator in the treatment of aggressive Non-Hodgkin's Lymphoma-comparison with CT.
    Mikhaeel NG, Timothy AR, O'Doherty MJ, Hain S, Maisey MN.
    Leuk Lymphoma; 2000 Nov 29; 39(5-6):543-53. PubMed ID: 11342337
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.